(Q41681294)

7 October 2017

1 reference

title

Acquired von Willebrand disease: concise review of occurrence, diagnosis, pathogenesis, and treatment (English)

1 reference

7 October 2017

1

Tefferi A

1 reference

7 October 2017

Nichols WL

2

1 reference

7 October 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

American Journal of Medicine

7 October 2017

published in

1 reference

7 October 2017

volume

103

1 reference

7 October 2017

issue

6

1 reference

7 October 2017

page(s)

536-540

1 reference

Four cases of acquired von Willebrand's syndrome

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von Willebrand's syndrome with IgM inhibitor against von Willebrand's factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von Willebrand's syndrome in association with a lupus-like anticoagulant corrected by intravenous immunoglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Hypothyroidism as a cause of acquired von Willebrand's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von Willebrand's disease and hypothyroidism: report of a case presenting with menorrhagia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Hypothyroidism and acquired von Willebrand disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von Willebrand disease in twins with autoimmune hypothyroidism: response to desmopressin and L-thyroxine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Pathogenesis of antibody-induced acquired von Willebrand Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von Willebrand's disease: demonstration of a circulating inhibitor to the factor VIII complex in four cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Unique multimeric pattern of von Willebrand factor in a patient with a benign monoclonal gammopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Clinical effectiveness of desmopressin in a case of acquired von Willebrand's syndrome associated with benign monoclonal gammopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von Willebrand disease associated with free lambda light chain monoclonal gammopathy, normal bleeding time and response to prednisone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Effectiveness of high-dose intravenous immunoglobulin in a case of acquired von Willebrand syndrome with chronic melena not responsive to desmopressin and factor VIII concentrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Expression of GpIb on plasma cells in a patient with monoclonal IgG and acquired von Willebrand disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

DDAVP in acquired von Willebrand syndrome associated with multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von Willebrand disease due to inhibitor of human myeloma protein specific for von Willebrand factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Absence of a bleeding tendency in severe acquired von Willebrand's disease. The role of platelet von Willebrand factor in maintaining normal hemostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von Willebrand disease in multiple myeloma secondary to absorption of von Willebrand factor by plasma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

The efficacy of intensive plasma exchange in acquired von Willebrand's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired type II von Willebrand's disease: demonstration of a complexed inhibitor of the von Willebrand factor-platelet interaction and response to treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Effectiveness of high-dose intravenous gamma globulin therapy in acquired von Willebrand's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Profound alterations of the multimeric structure of von Willebrand factor in a patient with malignant lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired Von Willebrand's syndrome associated with hairy cell leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von Willebrand's syndrome. Therapeutic and diagnostic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von Willebrand's disease caused by a chronic granulocytic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired type I von Willebrand's disease in a patient with essential thrombocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von Willebrand syndrome due to an inhibitor specific for von Willebrand factor antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von Willebrand disease and storage pool disease in chronic myelocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Demonstration of abnormal factor VIII multimers in acquired von Willebrand's disease associated with a circulating inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von Willebrand disease in patients with polycythemia rubra vera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von Willebrand's syndrome due to an inhibitor of IgG specific for von Willebrand's factor in polycythemia rubra vera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Essential thrombocythemia with acquired von Willebrand's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von Willebrand's disease in association with essential thrombocythemia: regression following treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: relationship with platelet count

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Abnormality of von Willebrand factor in patients with hemoglobin E-beta (0) thalassemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von Willebrand disease in a patient with Wilms tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von Willebrand disease in Wilms' tumor patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von Willebrand disease: correction of hemostatic defect by high-dose intravenous immunoglobulins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired type II von Willebrand's disease associated with adrenal cortical carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von willebrand disease in malignant peripheral neuroectodermal tumor (PNET)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von Willebrand's disease, platelet-release defect and angiodysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von Willebrand disease associated with an inhibitor to factor VIII antigen and gastrointestinal telangiectasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Gastrointestinal bleeding, angiodysplasia of the colon and acquired von Willebrand's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

"Angiodysplasia' of the tongue with acquired von Willebrand's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Characterization of two cases of acquired transitory von Willebrand syndrome with ciprofloxacin: evidence for heightened proteolysis of von Willebrand factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Development of a von Willebrand-like syndrome after prolonged use of hydroxyethyl starch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Induction of von Willebrand disease type I by valproic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

A hemorrhagic syndrome in Waldenström's macroglobulinemia secondary to immunoadsorption of factor VIII. Recovery after splenectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Mutation in the gene encoding the alpha chain of platelet glycoprotein Ib in platelet-type von Willebrand disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

A critical reappraisal of the bleeding time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Laboratory diagnosis of von Willebrand's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Laboratory diagnosis of von Willebrand's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Relative value of diagnostic studies for von Willebrand disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Laboratory assessment of von Willebrand factor. Use of different assays can influence the diagnosis of von Willebrand's disease, dependent on differing sensitivity to sample preparation and differential recognition of high molecular weight VWF forms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Gastro-intestinal bleeding in acquired von Willebrand's disease: efficacy of high-dose immuno-globulin where substitution treatments failed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

High-dose intravenous gammaglobulin therapy for acquired von Willebrand disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

Acquired von Willebrand's Disease Caused by a Monoclonal Antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900239-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(97)00239-8

1 reference

7 October 2017

1 reference